NCT02466958View on ClinicalTrials.gov

Trial of Levomilnacipran in Geriatric Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 9, 2018

Study Completion Date

December 9, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

levomilnacipran

antidepressant

DRUG

Placebo

an inactive drug

Trial Locations (1)

90095

UCLA Semel Institute - Neuropsychiatric Institute (NPI), Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT02466958 - Trial of Levomilnacipran in Geriatric Depression | Biotech Hunter | Biotech Hunter